Articles tagged with Vaccination
Researchers found a two- or three-dose schedule may be as effective as the traditional four-dose schedule in preventing pneumococcal disease in young children. The vaccine showed high effectiveness against seven strains of Streptococcus pneumoniae, with 96% efficacy in healthy children and 81% in those at risk.
A new MUHC study provides conclusive evidence that the MMR vaccine is not associated with autism spectrum disorders. The study's findings contradict previous molecular studies that falsely linked the vaccine to autism. The research team uncovered fundamental errors in these earlier studies, clearing the MMR vaccine of its link to autism.
States with personal belief exemptions and easily accessible immunization exemptions experience higher rates of whooping cough, according to a study published in JAMA. The study found that states granting personal belief exemptions had higher exemption rates, leading to increased incidence of pertussis.
The European Union should make vaccination against the human papillomavirus (HPV) mandatory for all girls aged 11-12 years to prevent cervical cancer. The vaccine offers protection against HPV types 16 and 18, responsible for 70% of all cervical cancers.
Researchers developed a DNA-based vaccine to protect against ragweed allergies, showing a 60% reduction in symptoms. The vaccine works by suppressing acute reactions and helping the body regulate chronic inflammation.
Researchers discovered that West Nile virus blocks immune signaling by a protein receptor, allowing it to replicate and spread. The African strain does not block this activity, making it harmless to the immune system. Harnessing this strain could lead to vaccine development against North American strains.
OHSU researchers show that CD8+ T-cells can literally eat virus-infected cells, providing insight into the human immune system and potential new way to gauge vaccine effectiveness. The discovery may help determine vaccine efficacy by measuring T-cell response to and consumption of a candidate vaccine.
A landmark publication from 100 authors offers comprehensive guidance on HPV vaccine administration and cervical cancer screening. The monograph addresses the challenges of expanding HPV-based screening to new populations and recommends universal vaccination strategies for both genders.
Radiation therapy significantly reduces risk of subsequent mastectomy and invasive breast cancer in both low- and high-risk patients with ductal carcinoma in situ (DCIS). Autoimmune conditions are also associated with increased risk of Hodgkin lymphoma, according to two new studies.
Researchers found that children exposed to polychlorinated biphenyls (PCBs) receive lower antibody protection after vaccinations. The study suggests that reducing exposure to chemicals that harm immune systems is crucial for young children.
A new study published in Vaccine found that a recombinant Protective Antigen (PA) protein vaccine produced the desired immune response in healthy adults, justifying further testing. The investigational vaccine demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response.
A new anti-obesity vaccine has shown promising results by slowing down weight gain and reducing body fat in animal models. The vaccine, targeting the hormone ghrelin, allowed rats to maintain normal eating habits while gaining less weight and accumulating less fat.
The Baylor Institute for Immunology Research has been awarded a $3 million grant to develop vaccines against melanoma, a deadly form of skin cancer. The research will focus on using dendritic cells to modulate the immune system and stimulate an anti-cancer response.
A study by Dr. Eric Fombonne and colleagues found no link between MMR vaccinations and autism rates in Quebec children, contradicting previous concerns. The incidence of autism remained high despite reductions in thimerosal use.
Researchers developed a strategy combining two human monoclonal antibodies to combat SARS virus, offering potential breadth of protection against all strains and preventing escape variants. The study presents the characteristics of this antibody combination in cell-culture experiments.
A heat-shock protein vaccine was found to reduce alveolar bone loss in patients with periodontal disease. The vaccine eradicated multiple pathogenic species, suggesting its potential as a treatment for periodontal disease.
A study shows that a prostate cancer vaccine, sipuleucel-T, can increase survival by up to four-and-a-half months and provide a greater than three-fold increase in survival at 36 months compared to patients in the placebo group. The vaccine was well-tolerated with mild adverse effects.
The introduction of Gardasil in the USA is proving problematic due to social and cultural resistance. The Bill and Melinda Gates Foundation has donated $27.7 million to PATH to research introducing the vaccine in developing countries, where Merck and GSK can assist by identifying cultural barriers.
University of Rochester experts discuss how flu invades and responds to the body, with a focus on understanding its pathogenesis. The research aims to prevent potential modification of the flu virus for lethal use and develop more effective treatments.
Researchers have identified a protein peptide that regulates the immune system and prevents autoimmune disease in Type 1 diabetes. The peptide, p277, stimulates regulatory T cells to produce anti-inflammatory substances, weakening the immune response.
A new vaccine called NicVax is being tested to prevent and treat nicotine addiction, with the goal of helping smokers quit. The vaccine works by stimulating the immune system to produce antibodies that recognize nicotine molecules, preventing them from entering the brain.
Dental caries is a widespread and increasing problem globally, with 5 billion people affected. Forsyth researchers aim to develop a vaccine targeting bacterial accumulation on teeth, with initial focus on mucosal vaccines for young children.
A study conducted by Yale University researchers found that Iraqi nurses require improved working conditions, equipment, and financial support to ensure the success of the healthcare system. The nurses also emphasized the importance of respect from physicians, administrators, and society at large.
Researchers found that a vaccine combined with short-term antibiotic treatment can protect nonhuman primates from inhalational anthrax. The study suggests that this combination may be crucial for successful defense against large-scale anthrax attacks, minimizing the risk of adverse events and improving public health management.
A combination of interventions could be highly effective at reducing transmission in a flu pandemic, potentially saving many lives. School closure combined with antiviral drugs can halve the number of people getting ill.
A new experimental vaccine has been shown to protect nonhuman primates against Marburg virus infection, even when administered after exposure. The study found that all treated monkeys survived for at least 80 days, while controls succumbed to the disease within 12 days.
Researchers have developed a vaccine that prevents haemorrhagic fever developing in monkeys infected with the deadly Marburg virus. The vaccine was found to be highly effective as a post-exposure treatment, with all treated monkeys surviving for at least 80 days.
Negative publicity in 1998 led to a sharp increase in MMR vaccine uptake among nursery school children, with the sharpest decline occurring for those born from 1999 onwards. The most affluent sectors tended to vaccinate early or not at all, while parents in deprived areas delayed vaccination.
Researchers found that blood tests T-SPOT.TB and QuantiFERON-TB Gold show good diagnostic agreement with the skin test, but have higher specificity. This suggests they could increase diagnostic sensitivity in testing for latent TB infection. However, results differ between blood tests, especially in immunosuppressed patients and young ...
Researchers propose a $500 million upfront investment to secure a 12-month vaccine supply, protecting 11,000 daily births from potential shortages. The CDC's six-month plan is deemed unclear given the actual production interruption timelines.
A new analysis reveals that combination vaccines significantly increased on-time immunization rates in infants. The study found that the combination group had a 42.7% on-time rate for the HEDIS Combo 2 series, compared to 34.9% in the component group.
The BCG vaccine is highly cost-effective in preventing severe childhood tuberculosis, with an estimated cost of US$200 per year of healthy life gained. The largest impact was found in southeast Asia, Africa, and the western Pacific region, where TB infection rates and BCG coverage are highest.
A vaccine against cervical cancer has shown sustained high levels of antibodies for up to 4.5 years, providing substantial long-term protection against cancerous cell changes associated with high-risk HPV types. The vaccine was also found to be effective against persistent and new infections, setting the stage for its widescale adoption.
A new approach to controlling swine disease, known as acclimatization, was tested on a farm in Illinois. The study found that pigs exposed to the farm's wild-type virus developed immunity but suffered reproductive issues, casting doubt on its effectiveness.
The HPV vaccine has the potential to prevent cervical cancer, but understanding its context is vital. Vaccination should not be misconstrued as a green light for permissive behavior, but rather as a means of preventing infection in young women.
Researchers recommend vaccination campaigns, visa quotas, and rapid repatriation to minimize health hazards during the Hajj. International collaboration is crucial in managing the overwhelming task of Hajj management.
Researchers found that atopic dermatitis patients have lower levels of disease-fighting antimicrobial peptides, making them more susceptible to eczema vaccinatum. A potential therapy involving LL-37 and IL-13 neutralization could offer protection against this life-threatening side effect.
A new study reveals that people with eczema may benefit from smallpox vaccination due to their immune system's overproduction of inflammation-promoting molecules. The research suggests that developing drugs or creams to mimic the action of LL-37 or neutralizing IL-4 and IL-13 could be effective in boosting the immune response.
A survey of medical and non-medical experts predicts a high risk of avian flu pandemic, with only a 15% chance of the US having sufficient vaccines. The greatest hope for mitigation lies in heightened global surveillance, hand washing, mask wearing, and social distancing.
The study found that combination vaccine groups had significantly higher coverage rates for various vaccines, including DTaP, polio, and hepatitis B. Additionally, children in the combination cohort received their vaccinations on time more frequently than those in the component cohort.
A study of 372 children found that ibuprofen and acetaminophen were ineffective in preventing local reactions to the DTaP vaccine, which can cause swelling and discomfort. The researchers suggest alternative approaches, such as using a lower antigen content vaccine, may be more effective in reducing reaction rates.
A Phase 1 trial of an Ebola DNA vaccine demonstrated strong immune responses in all fully vaccinated volunteers. The vaccine, developed by Vical, was well-tolerated and showed effectiveness against Ebola-specific antibodies.
The new rotavirus vaccine RotaTeq has been added to the routine infant immunization schedule in the US, following its approval by the FDA. The vaccine is expected to prevent severe cases of rotavirus gastroenteritis and reduce hospitalizations.
A study found that only 11% of eligible foreign-born women in Miami received postpartum vaccinations, highlighting the need for increased vaccination efforts to prevent congenital rubella syndrome. The Centers for Disease Control and Prevention recommend vaccination for all women of childbearing age without evidence of rubella immunity.
The Bank of America Charitable Foundation grant enables the Mailman School of Public Health's Northern Manhattan Start Right Coalition to scale up its community-based childhood immunization program. The program has seen a significant improvement in immunization rates, with an 80.5% current rate for children aged 19-35 months, exceeding...
A Phase 2 clinical study revealed that BiovaxID, a personalized anti-cancer vaccine, induced anti-tumor T-cell responses in most patients despite B-cell depletion. The overall survival rate was 89%, showing the vaccine's potential to treat other types of non-Hodgkin's lymphoma.
Three promising young science reporters from Latin America were selected by the program's recruitment committee to attend and report on the 2006 AAAS Annual Meeting. Lorena Guzmán from Chile, Roberta Jansen from Brazil, and Rosalía Servín Magaña from Mexico will receive full support to cover the conference.
U.S. researchers have developed a new vaccine candidate against hepatitis C using dendritic cells, which reduced the amount of carrier virus expressing HCV protein in mice by 100,000 times compared to controls. The study's findings offer a promising approach to prevent liver disease and eliminate the virus from the body.
A new plant-based system rapidly produces high levels of antigens that confer immunity against the plague. Guinea pigs vaccinated with the new antigen exhibited higher survival rates compared to traditional vaccines.
Researchers at Thomas Jefferson University have identified a molecular mechanism involved in making the rabies virus pathogenic and lethal. They have developed a very safe vaccine for the immunization of wildlife, showing efficacy in raccoon, skunk, and mongoose species, offering new hope for prevention of deadly disease.
A new oral vaccine, Rotateq, has been shown to virtually eliminate the most severe cases of rotavirus, a common childhood virus. The vaccine nearly eliminated serious rotavirus-related gastroenteritis and reduced hospital admissions by 96%.
Researchers have developed a new system of 'self-exploding' microcapsules that can release medication without external triggers. This technology has the potential to transform how vaccines are administered, allowing for more efficient and targeted treatments.
Researchers have developed a new approach that boosts the production of TAP, an immune system component, to make smaller vaccine doses more effective, reducing side effects and increasing immunization capacity. This technique has the potential to far-reaching benefits in the field of vaccines.
A new Israeli study found that vaccinating all children against hepatitis A at 18 and 24 months reduced overall incidence of the disease for all ages by 95%. The study also showed a significant decrease in reported incidents among one- to four-year-olds, a demographic historically susceptible to infection.
Research reveals that pertussis toxin is responsible for prolonging the infection period in immune and vaccinated hosts. The study found that antibodies produced by vaccines are effective only seven days after administration, allowing the bacteria to grow and spread before the body can mount an effective response.
A UCF-led study successfully grew a safe and effective anthrax vaccine in tobacco plants, producing potent doses without bacterial toxins. The breakthrough method could help alleviate supply shortages and make vaccines more accessible worldwide.
A study of 37,901 civilians who received smallpox vaccine between 2003 and 2004 found 822 reports of adverse events, with 100 serious cases reported. No preventable life-threatening adverse reactions were identified, highlighting the effectiveness of vaccination screening and education.
Researchers are developing new methods for immunization, including transdermal and nasal delivery, which could prevent needle-caused infections and reduce economic burdens. Interdisciplinary efforts are underway to make needle-free immunizations a common practice.
Dr Cleaveland's project seeks to eliminate rabies by targeting its primary source: dogs. The research also sheds light on the role of wildlife in transmitting diseases between species.
Researchers have discovered a novel bacterial protein azurin that can selectively target and kill cancer cells, while also using electric pulses to deliver a gene therapy that stimulates an immune system attack. Additionally, a small nanoparticle has been developed to reduce side effects of radiation and chemotherapy treatment.